Matthew A. King

  • Home
  • Matthew A. King

Matthew A. King

Matthew A. King

Matthew A. King is a healthcare executive and venture capitalist based in Nashville. Mr. King serves as Managing Partner of Clayton and Associates FCA Ventures and of Diōko Health Ventures and is also Managing Partner of Triple Play Ventures, an investment partnership started in 1999.
Mr. King has over 35 years of business experience, the last 18 of which have been exclusively in the venture capital industry with a focus on healthcare services and information technology. He has participated in approximately 55 venture capital and private equity investments and has served as lead investor in 27 transactions for FCA Ventures. Mr. King currently serves on the Board of Directors of Clinical Ink, Inc., StudioNow, Inc., MediQuire, Inc., Remedly, Inc., HealthyBytes, Inc. Vericred, Inc., and all FCA or Diōko portfolio companies.  Mr. King assumes the Proxsys Rx Board seat previously held by Stuart McWhorter who now serves as Commissioner of Finance and Administration for the State of Tennessee.